Angiotensin-Converting Enzyme 3D structures
From Proteopedia
(Difference between revisions)
												
			
			| Line 1: | Line 1: | ||
| + | ==3D Structures of Angiotensin-Converting Enzyme==  | ||
| + | |||
| + | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}  | ||
| + | {{#tree:id=OrganizedByTopic|openlevels=0|  | ||
| + | |||
*Angiotensin Converting Enzyme  | *Angiotensin Converting Enzyme  | ||
Revision as of 09:19, 17 March 2019
3D Structures of Angiotensin-Converting Enzyme
Updated on 17-March-2019 {{#tree:id=OrganizedByTopic|openlevels=0|
- Angiotensin Converting Enzyme
 
- Angiotensin Converting Enzyme N domain (1-641) complex
 
- 2c6n, 1o86, 4c2p, 2ydm, 1uze, 1uzf, 6h5x - hANCE + anti-hypertensive drug
 - 6en5, 6en6, 4bzr - hANCE + inhibitor
 - 4bzs – hANCE (mutant) + inhibitor
 - 6f9r, 6f9t, 6f9u, 6f9v - hANCE + chronic heart failure drug
 - 3kbh, 3d0g, 3d0h, 3d0i, 2ajf, 3sci, 3scj, 3sck, 3scl, 6cs2, 6acg, 6acj, 6ack – hANCE 2 +spike glycoprotein
 
- 2c6n, 1o86, 4c2p, 2ydm, 1uze, 1uzf, 6h5x - hANCE + anti-hypertensive drug
 
- 4bxk, 4ca5, 4ca7, 4ca8, [[2xy9, [[2xyd – hANCE + phosphinic inhibitor
 - 4ca6 - hANCE N domain (mutant) + phosphinic inhibitor
 - 4aph – hANCE + angiotensin II
 - 4apj – hANCE + bradykinin-potentiating peptide B
 - 1r42, 1r4l – hANCE + disordered segment of collectrin homology domain
 - 2xhm – DmANCE+K inhibitor
 - 2x8z, 2x90, 2x91, 2x92, 2x93, 2x94, 2x95, 2x96, 2x97, 1j36, 1j37, 1j38, 3zqz – DmANCE+anti-hypertensive drug
 - 4aa1 – DmANCE + angiotensin II
 - 4aa2, 4asr – DmANCE + bradykinin-potentiating peptide B
 - 4asq – DmANCE + bradykinin peptide
 
- 4bxk, 4ca5, 4ca7, 4ca8, [[2xy9, [[2xyd – hANCE + phosphinic inhibitor
 
- Angiotensin Converting Enzyme C domain (642-1232) complex
 
}}
